Journals / Turkish Journal of Hematology / 2012 / Cilt: 29 - Sayı: 3

Orak hücre hastalığı olan 11 yaşında bir çocukta gelişen priapizmin otomatik eritrosit değişimi ve hiperbarik oksijen ile tedavisi

Treatment of priapism with automated red cell exchange and hyperbaric oxygen in an 11-year-old patient with sickle cell disease

Pages
270–273
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein we report an 11-year-old patient with sickle cell disease that presented with priapism 72 h after onset, and was successfully treated with automated red cell exchange and hyperbaric oxygen following unsuccessful surgical and conventional interventions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Priapism affects up to 50% of all males with sickle cell disease, and there is no standard treatment.
📊
Key Findings & Data:Delayed and unsuccessful treatment leads to corporal fibrosis and impotence.
💡
Conclusion & Impact:Herein we report an 11-year-old patient with sickle cell disease that presented with priapism 72 h after onset, and was successfully treated with automated red cell exchange and hyperbaric oxygen following unsuccessful surgical and conventional interventions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Priapism affects up to 50% of all males with sickle cell disease, and there is no standard treatment. Delayed and unsuccessful treatment leads to corporal fibrosis and impotence. It is therefore necessary to determine the best treatment methods for this complication in order to offer effective interventions to all affected patients. Herein we report an 11-year-old patient with sickle cell disease that presented with priapism 72 h after onset, and was successfully treated with automated red cell exchange and hyperbaric oxygen following unsuccessful surgical and conventional interventions.

Özet

Priapizm orak hücre hastalığı olan tüm erkeklerin yaklaşık yarısında ortaya çıkabilir ve tedavisinde henüz bir fikir birliği oluşmamıştır. Tedavinin başarısız olması ve gecikme korporal fibrozise ve impotansa neden olur. Priapizm gelişen hastalarda en etkili girişimsel yaklaşımı önerebilmek için bu komplikasyonun tedavisinin en iyi şekilde bilinmesine gereklilik vardır. Burada, orak hücre hastalığı olan,72 saattir süregelen priapizm komplikasyonu olan 11 yaşında bir çocuk hastanın cerrahi ve konvansiyonel girişimler yetersiz kaldıktan sonra, otomatik eritrosit değişimi ve hiperbarik oksijen ile başarılı tedavisini bildiriyoruz.

🔖

Cite This Article

AZIK, F. M., ATAY, A., KÜREKÇİ, A. E., Ay, H., KİBAR, Y., ÖZCAN, O. (2012). Orak hücre hastalığı olan 11 yaşında bir çocukta gelişen priapizmin otomatik eritrosit değişimi ve hiperbarik oksijen ile tedavisi. Turkish Journal of Hematology, Cilt: 29 - Sayı: 3, 270–273. https://ajindex.com/articles/412634

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Muthall JP, Honig SC. Priapism: Etiology and Management. Acad Emerg Med 1996: 3: 810-816 2. Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction and priapism. In: Walsh PC, Retik AB, Darracott Vaughan E Jr, Wein AJ editor(s). Campbell’s Urology. 7th Edition. Vol. 2, Philadelphia: W.B. Saunders, 1998: 1155–1180 3. Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980
  2. 1437 4. Fowler JE Jr, Koshy M, Strub M, Chinn SK. Priapism associated with the sickle cell hemoglobinopathies: Prevalence, natural history and sequelae. J Urol 1991
  3. 68 5. Mandatakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. J Ped Hematol Oncol 1999
  4. 522 6. Hasen HB, Raines SL. Priapism associated with sickle cell disease. J Urol 1962
  5. 76 7. Tarry WF, Duckett JW, Synder HM 3rd. Urological complications of sickle cell disease in pediatric population. J Urol 1987
  6. 594 8. McCarthy LJ, Vattuone J, Weidner J, Skipworth E, Fernandez C, Jackson L, Rothenberger S, Waxman D, Miraglia C, Porcu P, Danielson CF. Do Automated Red Cell Exchanges Relieve Priapism In Patients with Sickle Cell Anemia? Ther Apher 2000
  7. 258 9. Powars DR, Johnson CS. Priapism. Hematol Oncol Clin North Am 1996
  8. 1372 10. Serjeant GR, Serjeant BE. Sickle cell disease. 3rd edition. New York: Oxford University Press
  9. 2001 11. Hamre MR, Harmon EP, Kirkpatrick DV, Stern MJ, Humbert JR. Priapism as a complication of sickle cell disease. J Urol 1991
  10. 5 12. Serjeant GR, De Ceulaer K, Maude GH. Stilboestrol and stuttering priapism in homozygous sickle cell disease. Lancet 1985
  11. 1276 13. Dewan PA, Tan HL, Auldist AW, Moss DI. Priapism in childhood. Br J Urol 1989
  12. 545 14. Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, Bareford D, Akenova A, Akinyanju O, Cinkotai K, O’Reilly PH. Priapism in sickle-cell disease
  13. incidence, risk factors and complications-an international multicentre study. BJU Int 2002
  14. 898–902 15. Chakrabarty A, Upadhyay J, Dhabuwala CB, Sarnaik S, Perlmutter AD, Connor JP. Priapism associated with sickle cell hemoglobinopathy in children: Long-term effects on potency. J Urol 1996
  15. 1419–1423 16. Maples BL, Hagemann TM. Treatment of priapism in pediatric patients with sickle cell disease. Am J Health Syst Pharm 2004
  16. 355–363 17. Francis RB, Johnson CS